Showing results (111-120 of 267) with videos related to

Sort By:
Pageof 27
Frontiers in Pharmacology|October 4, 2014
The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT studyAnh N Do, Marguerite R Irvin, Amy I Lynch, et al.
Lipids in Health and Disease|June 27, 2020
A lipidome-wide association study of the lipoprotein insulin resistance indexMinoo Bagheri, Hemant K Tiwari, Anarina L Murillo, et al.
Pharmacogenetics and Genomics|February 17, 2012
Rare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network StudyMarguerite R Irvin, Qunyuan Zhang, Edmond K Kabagambe, et al.
Plos One|June 3, 2022
Telomere shortening and the transition to family caregiving in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) studyNicole D Armstrong, Marguerite R Irvin, William E Haley, et al.
AIDS (London, England)|December 17, 2009
A genome-wide association study of carotid atherosclerosis in HIV-infected menSadeep Shrestha, Marguerite R Irvin, Kent D Taylor, et al.
Plos One|October 30, 2016
Heritable DNA Methylation in CD4+ Cells among Complex Families Displays Genetic and Non-Genetic EffectsKenneth Day, Lindsay L Waite, Arnald Alonso, et al.
Aging Clinical and Experimental Research|October 21, 2019
Transitions to family caregiving: enrolling incident caregivers and matched non-caregiving controls from a population-based studyDavid L Roth, William E Haley, J David Rhodes, et al.
Pharmacogenetics and Genomics|January 10, 2012
A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet NetworkStella Aslibekyan, Edmond K Kabagambe, Marguerite R Irvin, et al.
Circulation|November 18, 2017
PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)Matthew T Mefford, Robert S Rosenson, Mary Cushman, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 15, 2012
Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet NetworkS Aslibekyan, P An, A C Frazier-Wood, et al.
Pageof 27